(Q53338097)

13 May 2018

title

Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease. (English)

1 reference

13 May 2018

author

Harald Hampel

series ordinal

3

1 reference

13 May 2018

Bruno Vellas

series ordinal

2

object named as

Bruno Vellas

1 reference

13 May 2018

1

Paul S Aisen

1 reference

13 May 2018

15 March 2013

1 reference

13 May 2018

Nature Reviews Drug Discovery

published in

1 reference

13 May 2018

volume

12

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

324

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/nrd3842-c1

exact match

0 references

cites work

Sting of Alzheimer's failures offset by upcoming prevention trials.

1 reference

https://api.crossref.org/works/10.1038%2FNRD3842-C1

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD3842-C1

Testing the right target and right drug at the right stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD3842-C1

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD3842-C1

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD3842-C1

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD3842-C1

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD3842-C1

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD3842-C1

Down's syndrome and Alzheimer's disease: towards secondary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD3842-C1

21 January 2018

Identifiers

DOI

10.1038/NRD3842-C1

1 reference

13 May 2018

PubMed ID

23493086

1 reference

13 May 2018